Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Prolonged QT interval, syncope, and delirium with galantamine.

Fisher AA, Davis MW.

Ann Pharmacother. 2008 Feb;42(2):278-83. doi: 10.1345/aph.1K514. Epub 2008 Jan 8.

PMID:
18182475
2.

Sibutramine-associated QT interval prolongation and cardiac arrest.

Ernest D, Gershenzon A, Corallo CE, Nagappan R.

Ann Pharmacother. 2008 Oct;42(10):1514-7. doi: 10.1345/aph.1L129. Epub 2008 Aug 26.

PMID:
18728104
3.

Probucol-induced QT prolongation and syncope.

Tamura M, Ueki Y, Ohtsuka E, Oribe M, Seita M, Oribe K, Ito M.

Jpn Circ J. 1994 May;58(5):374-7.

PMID:
8022053
4.

A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use.

Chiu MH, Al-Majed NS, Stubbins R, Pollmann D, Sandhu RK.

BMC Res Notes. 2016 Jun 14;9:310. doi: 10.1186/s13104-016-2105-4.

5.

Indapamide induced syncope in a patient with long QT syndrome.

Wang CP, Guo GB.

Pacing Clin Electrophysiol. 2002 Sep;25(9):1397-9.

PMID:
12380780
6.

QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine.

Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG.

Ann Pharmacother. 2005 Mar;39(3):543-6. Epub 2005 Feb 1.

PMID:
15687478
7.

Overdrive pacing in quinidine syncope and other long QT-interval syndromes.

DiSegni E, Klein HO, David D, Libhaber C, Kaplinsky E.

Arch Intern Med. 1980 Aug;140(8):1036-40.

PMID:
7396607
8.

Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.

Keivanidou A, Arnaoutoglou C, Krommydas A, Papanikolaou G, Tsiptses K, Chrisopoulos C, Kirpizidis C.

Cardiol J. 2009;16(2):172-4.

9.

Memantine-induced myoclonus and delirium exacerbated by trimethoprim.

Moellentin D, Picone C, Leadbetter E.

Ann Pharmacother. 2008 Mar;42(3):443-7. doi: 10.1345/aph.1K619. Epub 2008 Feb 26.

PMID:
18303133
10.

Kearns-Sayre syndrome associated with trifascicular block and QT prolongation.

Karanikis P, Korantzopoulos P, Kountouris E, Dimitroula V, Patsouras D, Pappa E, Siogas K.

Int J Cardiol. 2005 May 11;101(1):147-50.

PMID:
15860400
11.

Ciprofloxacin-induced Q-T interval prolongation.

Knorr JP, Moshfeghi M, Sokoloski MC.

Am J Health Syst Pharm. 2008 Mar 15;65(6):547-51. doi: 10.2146/ajhp070081.

PMID:
18319500
12.

Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature.

Paulison B, Léos CL.

Cardiovasc Toxicol. 2010 Dec;10(4):306-10. doi: 10.1007/s12012-010-9088-5. Review.

PMID:
20865460
13.

[A case of cardiogenic syncope in a drug-addict patient].

Portale G, Straccamore F, Mazzone M, Mirabella C, Carbone L, Pignataro G, Testa A, Covino M, Gentiloni Silveri N.

Ital Heart J Suppl. 2004 Oct;5(10):824-8. Italian.

PMID:
15615354
14.

Long QT syndrome unmasked in an adult subject presenting with excited delirium.

Bozeman WP, Ali K, Winslow JE.

J Emerg Med. 2013 Feb;44(2):e207-10. doi: 10.1016/j.jemermed.2012.02.054. Epub 2012 May 31.

PMID:
22658229
15.

Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.

Gareri P, De Fazio P, Cotroneo A, Lacava R, Gallelli L, De Fazio S, De Sarro G.

Arch Gerontol Geriatr. 2007;44 Suppl 1:199-206.

PMID:
17317453
16.

Valproate-induced delirium in a demented patient.

Gareri P, Lacava R, Cotroneo A, Bambara V, Marigliano N, Castagna A, Costantino DS, Ruotolo G, de Sarro G.

Arch Gerontol Geriatr. 2009;49 Suppl 1:113-8. doi: 10.1016/j.archger.2009.09.019.

PMID:
19836623
17.

QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.

Ando K, Hombo T, Kanno A, Ikeda H, Imaizumi M, Shimizu N, Sakamoto K, Kitani S, Yamamoto Y, Hizume S, Nakai K, Kitayama T, Yamamoto K.

J Pharmacol Sci. 2005;99(5):487-500.

18.

The electrocardiogram in the patient with syncope.

Dovgalyuk J, Holstege C, Mattu A, Brady WJ.

Am J Emerg Med. 2007 Jul;25(6):688-701. Review.

PMID:
17606095
19.

Hydroxyzine, a first generation H(1)-receptor antagonist, inhibits human ether-a-go-go-related gene (HERG) current and causes syncope in a patient with the HERG mutation.

Sakaguchi T, Itoh H, Ding WG, Tsuji K, Nagaoka I, Oka Y, Ashihara T, Ito M, Yumoto Y, Zenda N, Higashi Y, Takeyama Y, Matsuura H, Horie M.

J Pharmacol Sci. 2008 Dec;108(4):462-71. Epub 2008 Dec 5.

20.

Polymorphic ventricular tachycardia in a woman taking cesium chloride.

Saliba W, Erdogan O, Niebauer M.

Pacing Clin Electrophysiol. 2001 Apr;24(4 Pt 1):515-7.

PMID:
11341093

Supplemental Content

Support Center